Lung cancer is the most lethal form of cancer globally, with five-year survival following diagnosis varying between 5% to 25%. Around 20% of lung cancer patients are “non-smokers,” indicating that there are other risk factors and determinants besides tobacco smoking that might contribute to the development of this disease. LUCIA is an interdisciplinary project that…
Mark your Are you interested in the latest innovations in the life sciences and healthcare industries? Do you want to discover promising startups and projects in the MedTech and BioTech fields? calendars for the Life Science Investment Readiness Series – Israel Edition, which is set to take place on May 16th, 2023, in Tel Aviv.…
To kick off the Barcelona Health Innovation Week, Biocat presented the 2022 BioRegion Report, a benchmark study that analyses the life sciences and healthcare sector in Catalonia. In particular, the report demonstrates that Catalonia has been able to buck the macroeconomic trends and uncertainties to raise record levels of investment for innovation, particularly start ups.…
Nimble Diagnostics has raised over €1 million in a round led by Grow Ventures and Namarel Ventures, with participation from Inveniam Group, who acted as a syndicate of various business angels. Nimble is a MedTech spin-off from the Health Science Research Germans Trias i Pujol Institute (IGTP), the Polytechnic University of Catalonia (UPC), and the…
#CRAASHbcn 2022 the acceleration program that helps researchers and entrepreneurs bring to market innovations in the healthtech field, has officially kicked off! During this three-day event, they have gathered all participants, teams, and mentors had the opportunity to meet with each other, collaborate, and start working on their projects. Inveniam Group’s partner, Elena Canetti, is one…
On May 4th and 5th, 2022 the elephants team participated in the Kick-off Meeting of the TAONas-LUAD EIC Transition Grant at Centre for Genomic Regulation (CRG). Elena Canetti, Jesús Purroy, Cristina Vilarmau Marsinyach, and Isabel Espejo Díaz from Inveniam Group attended the event. We are honored to be an official member of this EIC consortium with CRG, SINTEF, and INSERM. The…
Predictheon SL, a spin-off of the Hospital Clínic of Barcelona, the University of Navarra, and the University of San Buenaventura in Cali, has closed its first investment round of €840,000. This transaction has been led by the University of Navarra I+D+I Technology Transfer Fund, under the management of Clave, the VC firm. It has been…
We are happy to announce that our colleagues from Devicare have closed a USD$3M Series A funding that will advance the development of Lit-Control, a non-surgical solution to kidney stones. Inveniam has advised in the round and the closing of the investment of Ship2B.
We are happy to announce that our colleagues from NEOS Surgery have received €1.9 million from the European Commission to improve herniated disc treatment.
At Inveniam Group, we would like to congratulate Dr. Rafael Correa Rocha, head of the Immune-Regulation Laboratory of Gregorio Marañón Hospital, for participating in a European consortium that promotes research on cellular immunotherapies to cope with Covid-19. The consortium is coordinated by the Hospital Clínic de Barcelona – IDIBAPS with support of the company Cellnex Telecom.